Abeona Therapeutics (ABEO) Reports In-Line Q1 EPS
Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.54), in-line with the analyst estimate of ($0.54).
For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.
Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.54), in-line with the analyst estimate of ($0.54).
For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.